Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology presented results from its SUMMIT Trial, Metastatic Breast Cancer, in a poster presentation at ASCO 2022.